Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

SRNE Relative to the S&P 500

SRNE Relative to the Sector

Seasonal Chart Analysis

Analysis of the Sorrento Therapeutics, Inc. (OTCMKT:SRNE) seasonal charts above shows that a Buy Date of May 19 and a Sell Date of August 22 has resulted in a geometric average return of 37.93% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 137.93% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments. The Sorrento Therapeutics segment consists of developing a portfolio of next generation treatments for three major therapeutic areas: cancer, infectious disease, and pain. The Scilex segment is largely organized around the company’s non-opioid pain management operations. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.

To download SRNE seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: SRNE